Mariadason JM - Search Results

1

Dual targeting of the epidermal growth factor receptor using the combination of cetuximab and erlotinib: preclinical evaluation and results of the phase II DUX study in chemotherapy-refractory, advanced colorectal cancer.

Weickhardt AJ, Price TJ, Chong G, Gebski V, Pavlakis N, Johns TG, Azad A, Skrinos E, Fluck K, Dobrovic A, Salemi R, Scott AM, Mariadason JM, Tebbutt NC. Weickhardt AJ, et al. Among authors: mariadason jm. J Clin Oncol. 2012 May 1;30(13):1505-12. doi: 10.1200/JCO.2011.38.6599. Epub 2012 Mar 12. J Clin Oncol. 2012. PMID: 22412142 Clinical Trial.

2

PIK3CA mutation/PTEN expression status predicts response of colon cancer cells to the epidermal growth factor receptor inhibitor cetuximab.

Jhawer M, Goel S, Wilson AJ, Montagna C, Ling YH, Byun DS, Nasser S, Arango D, Shin J, Klampfer L, Augenlicht LH, Perez-Soler R, Mariadason JM. Jhawer M, et al. Among authors: mariadason jm. Cancer Res. 2008 Mar 15;68(6):1953-61. doi: 10.1158/0008-5472.CAN-07-5659. Cancer Res. 2008. PMID: 18339877 Free PMC article.

3

Gene expression profiling of primary and metastatic colon cancers identifies a reduced proliferative rate in metastatic tumors.

Ganepola GA, Mazziotta RM, Weeresinghe D, Corner GA, Parish CJ, Chang DH, Tebbutt NC, Murone C, Ahmed N, Augenlicht LH, Mariadason JM. Ganepola GA, et al. Among authors: mariadason jm. Clin Exp Metastasis. 2010;27(1):1-9. doi: 10.1007/s10585-009-9295-2. Epub 2009 Nov 1. Clin Exp Metastasis. 2010. PMID: 19882219

4

Strategies for overcoming inherent and acquired resistance to EGFR inhibitors by targeting downstream effectors in the RAS/PI3K pathway.

Weickhardt AJ, Tebbutt NC, Mariadason JM. Weickhardt AJ, et al. Among authors: mariadason jm. Curr Cancer Drug Targets. 2010 Dec;10(8):824-33. doi: 10.2174/156800910793357961. Curr Cancer Drug Targets. 2010. PMID: 20718704 Review.

5

Biomarkers of 5-FU response in colon cancer.

Mariadason JM, Tebbutt NC. Mariadason JM, et al. Cancer Biol Ther. 2011 Apr 15;11(8):771-2. doi: 10.4161/cbt.11.8.15109. Epub 2011 Apr 15. Cancer Biol Ther. 2011. PMID: 21343696 Free article. No abstract available.

6

Therapeutic targeting of the epidermal growth factor receptor in human cancer.

Dhomen NS, Mariadason J, Tebbutt N, Scott AM. Dhomen NS, et al. Crit Rev Oncog. 2012;17(1):31-50. doi: 10.1615/critrevoncog.v17.i1.40. Crit Rev Oncog. 2012. PMID: 22471663 Review.

7

Resistance to BRAF inhibition in BRAF-mutant colon cancer can be overcome with PI3K inhibition or demethylating agents.

Mao M, Tian F, Mariadason JM, Tsao CC, Lemos R Jr, Dayyani F, Gopal YN, Jiang ZQ, Wistuba II, Tang XM, Bornman WG, Bollag G, Mills GB, Powis G, Desai J, Gallick GE, Davies MA, Kopetz S. Mao M, et al. Among authors: mariadason jm. Clin Cancer Res. 2013 Feb 1;19(3):657-67. doi: 10.1158/1078-0432.CCR-11-1446. Epub 2012 Dec 18. Clin Cancer Res. 2013. PMID: 23251002 Free PMC article.

8

Global protein profiling reveals anti-EGFR monoclonal antibody 806-modulated proteins in A431 tumor xenografts.

Lee ST, Ji H, Greening DW, Speirs RW, Rigopoulos A, Pillay V, Murone C, Vitali A, Stühler K, Johns TG, Corner GA, Mariadason JM, Simpson RJ, Scott AM. Lee ST, et al. Among authors: mariadason jm. Growth Factors. 2013 Oct;31(5):154-64. doi: 10.3109/08977194.2013.824435. Epub 2013 Aug 20. Growth Factors. 2013. PMID: 23957735

9

Molecular imaging of death receptor 5 occupancy and saturation kinetics in vivo by humanized monoclonal antibody CS-1008.

Burvenich IJ, Lee FT, Cartwright GA, O'Keefe GJ, Makris D, Cao D, Gong S, Chueh AC, Mariadason JM, Brechbiel MW, Beckman RA, Fujiwara K, von Roemeling R, Scott AM. Burvenich IJ, et al. Among authors: mariadason jm. Clin Cancer Res. 2013 Nov 1;19(21):5984-93. doi: 10.1158/1078-0432.CCR-12-3104. Epub 2013 Sep 17. Clin Cancer Res. 2013. PMID: 24045184

10

BRAF inhibitor-driven tumor proliferation in a KRAS-mutated colon carcinoma is not overcome by MEK1/2 inhibition.

Andrews MC, Behren A, Chionh F, Mariadason J, Vella LJ, Do H, Dobrovic A, Tebbutt N, Cebon J. Andrews MC, et al. J Clin Oncol. 2013 Dec 10;31(35):e448-51. doi: 10.1200/JCO.2013.50.4118. Epub 2013 Nov 4. J Clin Oncol. 2013. PMID: 24190114 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

150 results

Search Page

Filters